The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Starpharma To Launch Anti-Viral Condoms
The first of its kind, the VivaGel® condom incorporates an antiviral compound to reduce the risk of exposure to viruses such as HIV, HSV and HPV.
Mead Johnson Opens US$325 Million Facility In Singapore
Seeking to stay close to the growing Asian pediatric nutrition market, Mead Johnson opens a new manufacturing and research facility in Singapore.
Guided, Konica Minolta Develop Clinical Test For Barrett’s Esophagus
Guided Therapeutics has entered into a partnership with Konica Minolta Opto to develop a non-invasive test for Barrett’s Esophagus using its biophotonic disease detection platform.
Simcere Receives CFDA Approval For Anti-Rheumatic Drug Iremod
The State Food and Drug Administration has approved Simcere Pharmaceutical Group's new anti-rheumatic drug, Iremod, used to treat symptoms of active rheumatic arthritis.
Intel Capital Invests US$40m In 10 Asian Companies
Intel Capital announces ten new and planned investments in Asian companies, totaling US$40 million, at the 12th annual Global Summit.
Japanese Researchers Develop Autism Detection System For Infants
Researchers in Japan have developed a new system that detects autism in infants using small fluctuations in eye movement.
Baxter China To Increase Rural Access To Renal Therapy
Baxter China has piloted a program to deploy a sustainable care and delivery model for peritoneal dialysis patients living in rural areas of the country.
Shanghai Fosun Acquires Israel-Based Alma Lasers For US$240m
Shanghai Fosun Pharma announced this week the joint acquisition of Caesarea, Israel-based Alma Lasers Ltd.
Vectura & Partners Establish Kinnovata Pharma In China
UK-based Vectura Group plc has established Tianjin Kinnovata Pharmaceutical Company Limited in China with two partners.